Topics

FDA grants regulatory approval for hypoglycemia treatment

09:59 EDT 13 Sep 2019 | European Pharmaceutical Review

GVOKE injection has received regulatory approval from the FDA for the treatment of severe hypoglycemia in patients with diabetes.

The post FDA grants regulatory approval for hypoglycemia treatment appeared first on European Pharmaceutical Review.

Original Article: FDA grants regulatory approval for hypoglycemia treatment

NEXT ARTICLE

More From BioPortfolio on "FDA grants regulatory approval for hypoglycemia treatment"

Quick Search